NTH.MC BME
Naturhouse Health, S.A.
1W: -10.2%
1M: -11.3%
3M: -13.4%
YTD: -13.4%
1Y: +21.6%
3Y: +50.7%
5Y: +81.8%
€2.20 ($2.47)
-0.11 (-4.76%)
Weekly Expected Move ±4.6%
€2
€2
€2
€2
€2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$12M
-44.8% ▼
5Y CAGR: -10.1%
Capital Expenditures
$338K
+40.7% ▲
5Y CAGR: -17.5%
Free Cash Flow
$11M
-44.9% ▼
5Y CAGR: -9.8%
Dividends Paid
$12M
-100.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
-130.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $14M | $18M | $13M | $11M | $14M |
| Depreciation & Amort. | $3M | $2M | $2M | $2M | $2M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$799K | -$586K | -$3M | $107K | -$751K |
| Other Non-Cash Items | -$1M | -$4M | -$5M | $7M | -$3M |
| Operating Cash Flow | $15M | $16M | $7M | $21M | $12M |
| — Investing Activities — | |||||
| Capital Expenditures | -$201K | -$50K | -$964K | -$570K | -$338K |
| Acquisitions (Net) | $181K | -$4M | -$4M | $0 | $0 |
| Investment Purchases | -$181K | -$703K | -$692K | $0 | $0 |
| Investment Sales | $132K | $50K | $826K | $62K | $1M |
| Other Investing | $181K | -$48K | $0 | $49K | $189K |
| Investing Cash Flow | $112K | -$4M | -$5M | -$459K | $862K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | $1M | -$2M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$4M | -$18M | -$6M | -$12M |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$3M | -$6M | -$17M | -$8M | -$16M |
| Net Change in Cash | $11M | $6M | -$15M | $12M | -$4M |
| Cash End of Period | $22M | $27M | $12M | $24M | $21M |
| Free Cash Flow | $14M | $16M | $6M | $20M | $11M |